Loading...
Loading...
By Sergio Arturo Lievano Madrigal - Thu, 08/13/2026 - 11:29
Produce supplier Taylor Farms has been linked to two recent illness outbreaks, renewing scrutiny of US oversight of food imports from Mexico.
https://mexicobusiness.news/tag/fda
More Health
By Sergio Arturo Lievano Madrigal - Mon, 08/03/2026 - 11:48
AstraZeneca and Bristol Myers Squibb hold merger talks for a possible US$400 billion deal, say sources.
By Sergio Arturo Lievano Madrigal - Thu, 07/30/2026 - 12:56
Boehringer Ingelheim's 16.2% 1H26 sales growth coincides with a 22% rise in its Mexico clinical research investment for the year.
By MBN Staff - Wed, 07/29/2026 - 13:21
Mexican authorities found no evidence of Cyclospora cayetanensis at Taylor Farms after inspecting its Guanajuato facility.
By Eliza Galeana - Mon, 07/27/2026 - 10:51
Mexico reported record import of grains and oilseeds in 1H26. Meanwhile, the US and Mexico are working together to investigate a cyclospora outbreak.
By Sergio Arturo Lievano Madrigal - Fri, 07/24/2026 - 09:59
This week, Mexico commited MX$181 billion to hospitals, probed a cyclospora outbreak, and welcomed new pharma and insurtech investment.
By Fernando Mares - Tue, 07/21/2026 - 10:10
Health authorities confirmed three cyclosporiasis cases and joined the US CDC to investigate lettuce safety in Guanajuato.
By Eliza Galeana - Tue, 07/21/2026 - 08:18
Mexican health and agricultural authorities are working with the US FDA to investigate a cyclospora outbreak.
By Sergio Arturo Lievano Madrigal - Mon, 07/20/2026 - 12:03
FDA approves Merck's Lipfendra, the first oral PCSK9 pill for high cholesterol, as Mexico's pharma sector expands cardiovascular care.
By Marcos Pascual - Wed, 07/01/2026 - 08:00
Mexico's medical device market expands as primary care clinics adopt non-invasive tests for colorectal cancer, writes Marcos Pascual Cruz.
By Mauricio Peón García - Tue, 05/26/2026 - 07:00
The Medvi case highlights how AI allows small teams to scale rapidly, but warns against unethical fraud and fake data, writes Mauricio Peón.
